Rare Disease Day 2023: A look at Fabry Disease treatments developed in PHOENIX-OITB by ICMABers et al.
Within the European PHOENIX-OITB project, there are several partners, including ICMAB, that join efforts to advance the development of peptide targeted nanoliposomes for Fabry rare disease treatment.
Project Results, Breaking News, timeline
- Hits: 241